Ae Wealth Management LLC Gilead Sciences, Inc. Transaction History

Ae Wealth Management LLC

$9.76 Billion
Q3 2024

A detailed history of Ae Wealth Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ae Wealth Management LLC holds 48,967 shares of GILD stock, worth $4.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

48,967

Previous 29,796 64.34%

Holding current value

$4.4 Million

Previous $2.04 Million 100.78%

% of portfolio

0.04%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $1.28 Million - $1.61 Million	19,171 Added 64.34%	48,967 $4.1 Million
Q2 2024 Aug 12, 2024	BUY	$63.15 - $72.88 $197,280 - $227,677	3,124 Added 11.71%	29,796 $2.04 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $7.13 Million - $8.69 Million	-99,594 Reduced 78.88%	26,672 $1.95 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $4.72 Million - $5.36 Million	64,467 Added 104.32%	126,266 $10.2 Million
Q3 2023 Oct 11, 2023	BUY	$73.94 - $80.67 $440,238 - $480,309	5,954 Added 10.66%	61,799 $4.63 Million
Q2 2023 Jul 10, 2023	SELL	$76.01 - $86.7 $23 Million - $26.2 Million	-301,991 Reduced 84.39%	55,845 $4.3 Million
Q1 2023 Apr 14, 2023	BUY	$77.31 - $88.08 $2.9 Million - $3.31 Million	37,561 Added 11.73%	357,836 $29.7 Million
Q4 2022 Jan 31, 2023	BUY	$62.32 - $89.47 $2.68 Million - $3.85 Million	43,064 Added 15.53%	320,275 $27.5 Million
Q3 2022 Oct 25, 2022	BUY	$59.54 - $68.01 $12.7 Million - $14.5 Million	213,114 Added 332.49%	277,211 $17.1 Million
Q2 2022 Aug 03, 2022	BUY	$57.72 - $65.01 $368,426 - $414,958	6,383 Added 11.06%	64,097 $3.96 Million
Q1 2022 Apr 18, 2022	BUY	$57.92 - $72.58 $264,231 - $331,109	4,562 Added 8.58%	57,714 $3.43 Million
Q4 2021 Jan 20, 2022	SELL	$64.88 - $73.64 $495,229 - $562,094	-7,633 Reduced 12.56%	53,152 $3.86 Million
Q3 2021 Nov 01, 2021	BUY	$67.69 - $73.03 $365,526 - $394,362	5,400 Added 9.75%	60,785 $4.25 Million
Q2 2021 Jul 21, 2021	BUY	$63.47 - $69.35 $863,509 - $943,506	13,605 Added 32.56%	55,385 $3.81 Million
Q1 2021 Apr 27, 2021	SELL	$60.0 - $68.46 $294,120 - $335,590	-4,902 Reduced 10.5%	41,780 $2.7 Million
Q4 2020 Feb 01, 2021	BUY	$56.65 - $64.55 $172,612 - $196,683	3,047 Added 6.98%	46,682 $2.72 Million
Q3 2020 Nov 06, 2020	BUY	$62.1 - $78.08 $517,851 - $651,109	8,339 Added 23.63%	43,635 $2.76 Million
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $837,118 - $972,048	-11,572 Reduced 24.69%	35,296 $2.72 Million
Q1 2020 May 07, 2020	BUY	$62.63 - $80.22 $272,503 - $349,037	4,351 Added 10.23%	46,868 $3.5 Million
Q4 2019 Jan 15, 2020	BUY	$61.62 - $67.78 $96,188 - $105,804	1,561 Added 3.81%	42,517 $2.76 Million
Q3 2019 Nov 05, 2019	BUY	$62.51 - $69.0 $908,207 - $1 Million	14,529 Added 54.98%	40,956 $2.6 Million
Q2 2019 Jul 22, 2019	BUY	$61.87 - $69.38 $1.23 Million - $1.38 Million	19,916 Added 305.88%	26,427 $1.79 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $135,252 - $151,518	2,163 Added 49.75%	6,511 $423,000
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $63,203 - $82,476	-1,044 Reduced 19.36%	4,348 $272,000
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $72,491 - $80,261	1,017 Added 23.25%	5,392 $416,000
Q2 2018 Aug 15, 2018	SELL	$64.88 - $75.68 $765,194 - $892,569	-11,794 Reduced 72.94%	4,375 $310,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $16,024 - $19,536	-220 Reduced 1.34%	16,169 $1.22 Million
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $938,824 - $1.1 Million	13,195 Added 413.12%	16,389 $1.17 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $230,319 - $272,991	3,194	3,194 $259,000

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.

Account

Ae Wealth Management LLC Gilead Sciences, Inc. Transaction History